Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A descriptive term reflecting increased gyral folding in the frontoparietal regions as determined by magnetic resonance imaging. It has subsequently been shown to represent a cobblestone malformation on histopathology. BFPP typically presents with hypotonia, developmental delay, moderate to severe intellectual disability, pyramidal signs, epileptic seizures, non-progressive cerebellar ataxia, deconjugate gaze, and/or strabismus.
Features include always present findings: Hypertonia, Truncal ataxia, Dysmetria, and Perisylvian polymicrogyria and others; and very common findings: Seizure, Cerebral dysmyelination, Enlarged brain ventricles (ventriculomegaly), and Intellectual disability and others. 37 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 17 | Broad-based gait, Truncal ataxia, Babinski sign |
ADGRG1 encodes adhesion G protein-coupled receptor G1 (693 aa). Adhesion G-protein coupled receptor (aGPCR) for steroid hormone 17alpha-hydroxypregnenolone (17-OH), which is involved in cell adhesion and cell-cell interactions. Highest expression in Thyroid (115.6 TPM) and Kidney Medulla (94.0 TPM).
Bilateral frontoparietal polymicrogyria is caused by mutations in the ADGRG1 gene on chromosome 16.
ADGRG1 is classified as a druggable target (Druggable Genome and G Protein Coupled Receptor categories) with score 0.0.
56 pathogenic variants reported in ADGRG1 in ClinVar, including hotspot variants 888059 and 158631.
Variant |
|---|
Genetic testing for ADGRG1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 5 always present features, 7 very common features, 10 common features.
No clinical trials have been registered for bilateral frontoparietal polymicrogyria.
3 publications have been identified in PubMed for bilateral frontoparietal polymicrogyria. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Basic Science / Preclinical (33%).
Javed K (2026). [PMID: 41347281](https://pubmed.ncbi.nlm.nih.gov/41347281/). *Ann Hum Genet*. [Case Report / Case Series]
Kwarcinski FE (2026). [PMID: 42018412](https://pubmed.ncbi.nlm.nih.gov/42018412/). *Proc Natl Acad Sci U S A*. [Basic Science / Preclinical]
Qi W (2024). [PMID: 38942087](https://pubmed.ncbi.nlm.nih.gov/38942087/). *Biochem Pharmacol*. [Review / Meta-Analysis]
Data assembled from 8 of 12 sources · Last updated Sep 18, 2026, 7:14 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Eyes |
2 |
Nystagmus, Strabismus |
Head and neck | 2 | Abnormal facial shape, Microcephaly |
Review Stars |
|---|
Hotspot |
|---|
888059 | Conflicting classifications of pathogenicity | — | Yes |
158631 | Conflicting classifications of pathogenicity | — | Yes |
NP_001139242.1:p.Gln247fs | Pathogenic | 2 stars | Yes |